Navigation Links
CryoLife Announces Management Promotions
Date:8/4/2008

ATLANTA, Aug. 4 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that Bruce G. Anderson has been promoted to vice president of U.S. sales and marketing, and that Richard C. Gridley has been promoted to vice president of international sales and marketing. Both men will report to Gerald B. Seery, senior vice president of worldwide sales and marketing. Additionally, the company has announced the promotion of Timothy M. Neja to vice president of laboratory operations. Mr. Neja will report to D. Ashley Lee, executive vice president, chief operating officer and chief financial officer.

In his new position, Mr. Anderson, 42, will be responsible for the U.S. direct sales force, U.S. marketing, and customer service. Mr. Anderson began his career at CryoLife in 1994 as a territory manager and has held increasingly important roles within the sales and marketing organization, most recently serving as senior director, U.S. sales and marketing. Prior to joining CryoLife, Mr. Anderson was with Dun and Bradstreet Business Credit Services.

Mr. Gridley, 37, will now manage sales and marketing in Canada, Asia- Pacific, and Central and South America. Mr. Gridley joined CryoLife in 2005 as marketing manager for BioGlue(R) Surgical Adhesive and most recently served as marketing manager, global bioadhesives. Previously, Mr. Gridley was with Global Link Logistics, Inc., Rusch Inc. and 3M Company.

Mr. Neja, 42, has most recently served as senior director of laboratory operations at CryoLife. In his new role, he will continue to be responsible for all laboratory operations, including tissue processing and BioGlue manufacturing, as well as purchasing and facilities management. Prior to joining CryoLife in 1997 as production manager, Mr. Neja was with Centeon.

"We are pleased to announce these well-deserved promotions within our management team," said Steven G. Anderson, CryoLife president and chief executive officer. "Bruce, Rich and Tim have each made substantial contributions to the success of the organization over the past several years, and we believe they will continue to enhance our ability to bring cutting-edge solutions to cardiac and vascular surgeons world-wide."

About CryoLife, Inc.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the United States and Canada. The Company recently received FDA clearance for the CryoValve(R) SG pulmonary human heart valve, processed using CryoLife's proprietary SynerGraft(R) Technology. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R), a hemostatic agent, in much of the U.S. for use in cardiac and vascular surgery and in the United Kingdom and Germany for cardiac, vascular, and general surgery, subject to certain exclusions. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Community.

For additional information about the company, visit CryoLife's Web site: http://www.cryolife.com

Media Contacts:

D. Ashley Lee Katie Brazel

Executive Vice President, Chief Fleishman Hillard

Financial Officer and Phone: 404-739-0150

Chief Operating Officer

Phone: 770-419-3355


'/>"/>
SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLifes Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
2. CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2008 Financial Results
3. CryoLifes BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
4. CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference
5. Harvey Morgan Joins CryoLife Board of Directors
6. CryoLife Conducts Surgeons Cardiac Allograft Symposium
7. CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
8. CryoLife Closes on $15 Million Credit Facility with GE Healthcare Financial Services
9. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
10. CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
11. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... RoviSys, ... solutions, announced today the opening of an office in Taipei, Taiwan. This new ... China region, while developing new relationships in the region. Located in the Neihu ...
(Date:9/19/2017)... ... September 19, 2017 , ... Participants of this ... high-performance fume hood. Along with the advantages and disadvantages of ductless, filtered fume ... hoods in the laboratory. , Attendees will learn from an industry expert about ...
(Date:9/19/2017)... ... 2017 , ... VetStem Biopharma ’s CEO and founder, Dr. Bob Harman DVM, MPVM, is ... "Stem Cell Therapy: A Rising Tide". Dr. Harman and Dr. Riordan met in 2003 ... interest in the potential of stem cell therapy and a fast friendship was formed. , ...
(Date:9/19/2017)... Pleasanton, Calif. and Washington, D.C. (PRWEB) , ... ... ... to delivering rapid care during an biological outbreak is about to be eliminated, ... When asked what makes ExcitePCR’s FireflyDX™ technologies different than other pathogen ...
Breaking Biology Technology:
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
Breaking Biology News(10 mins):